INTRODUCTION
RNA interference (RNAi) acts as an antiviral response in plants, insects and invertebrates (Voinnet, 2001; Galiana-Arnoux et al, 2006; van Rij et al, 2006; Wang XH et al, 2006; Ding & Voinnet, 2007) . RNAi is induced by double-stranded RNA (dsRNA) viral replication intermediates and extended secondary structures in viral RNA (Voinnet, 2005) . These dsRNA molecules are recognized by Dicer proteins and processed into small interfering RNAs (siRNAs), which guide the RNA-induced silencing complex (RISC) to inactivate a target RNA in a sequence-specific manner (Sontheimer, 2005) . To counteract this antiviral response, plant and insect viruses encode RNA silencing suppressor (RSS) proteins (Voinnet, 2005) . Most plant viral RSS proteins have dsRNAbinding domains for short siRNAs (Voinnet, 2005; Lakatos et al, 2006; Merai et al, 2006) or longer dsRNAs (Merai et al, 2005; Deleris et al, 2006) . Other plant viral RSS proteins interfere with protein components of the RNAi machinery (Deleris et al, 2006; Levy et al, 2008) .
Mammalian cells have a functional RNAi pathway that can be instructed to become antiviral on transfection with siRNAs or constructs that express short hairpin RNAs against viral sequences (reviewed by Haasnoot et al, 2007; Marques & Carthew, 2007) . However, the potential role of RNAi as a natural antiviral defence mechanism in mammalian cells remains controversial. The characteristic of antiviral RNAi-that is, accumulation of virusderived siRNAs-could not be identified in infected cells (Pfeffer et al, 2004) ; however, such molecules have been described more recently for several endogenous and exogenous viruses, including human immunodeficiency virus type 1 (HIV-1; Bennasser et al, 2005; Soifer et al, 2005; Yang & Kazazian, 2006; Parameswaran et al, 2008) , and yet the significance of these findings is still being debated (Lin & Cullen, 2007) . There is accumulating evidence that mammalian cells use microRNAs (miRNAs) to control viruses (Berkhout & Jeang, 2007) . HIV-1 is inhibited by miR-17 and miR-20a owing to the downregulation of histone acetylase p300/ CBP-associated factor (PCAF), a cofactor of the transactivator of transcription (Tat) protein (Triboulet et al, 2007) . miRNAs might also regulate components of the antiviral interferon (IFN) pathway, and thus provide a possible link between the RNAi and IFN pathways (reviewed by Sonkoly et al, 2008) . These combined findings support the idea that RNAi, either siRNA-or miRNAbased, is part of the innate immune system in mammals.
Consistent with this idea, an increasing number of mammalian viruses have been shown to encode an RSS protein, for example, the hepatitis C virus (HCV) core and envelope protein 2 (Wang Y et al, 2006; Ji et al, 2008) , vaccinia virus E3L (Li et al, 2004) , Ebola virus VP35 , primate foamy virus Tas (Lecellier et al, 2005) , influenza A virus NS1 (Bucher et al, 2004; Li et al, 2004; Haasnoot et al, 2007) and HIV-1 Tat (Bennasser et al, 2005) . These RSS proteins suppress RNAi-mediated downregulation of a reporter gene construct. NS1 and VP35 can also trans-complement the production of a Tat-negative HIV-1 variant (Haasnoot et al, 2007) . HIV-1 Tat and HCV core were proposed to block the activity of Dicer (Bennasser et al, 2005; Chen et al, 2008) , whereas NS1, E3L and VP35 probably act by sequestering dsRNA (Bucher et al, 2004; Li et al, 2004; Haasnoot et al, 2007) . In addition, we showed that stable expression of mammalian RSS proteins increases virus replication .
Intriguingly, most identified RSS proteins of mammalian viruses also have IFN or protein kinase R (PKR) antagonistic properties, and these activities usually map to the RNA-binding domain, which is also implicated in RNAi function (Wang et al, 1999 (Wang et al, , 2000 Bucher et al, 2004) . To distinguish between the IFN and RNAi pathways, we used the NS3 protein of rice hoja blanca virus (RHBV) that binds exclusively to small dsRNAs and shows RSS activity in mammalian cells (Hemmes et al, 2007; Schnettler et al, 2008) . Consistent with this property, we confirm that this plant virus protein lacks IFN antagonistic activity and yet is able to rescue a Tat-negative HIV-1 variant.
RESULTS AND DISCUSSION
The plant virus NS3 protein complements Tat NS3 expression vectors were made that use the constitutive elongation factor (EF)-1a promoter. First, we tested protein expression in human embryonic kidney (HEK) 293T cells. NS3 is expressed as a fusion protein of 66 kDa with maltose-binding protein (MBP). The MBP domain is synthesized as a separate 43-kDa domain (Fig 1A) . Functional complementation with a well-defined RSS protein is an effective strategy to identify new RSS functions (Li et al, 2004) . For example, the Ebola virus VP35 protein can complement a Tat-negative HIV-1 variant in which the Tet system for doxycycline (dox)-inducible gene expression replaces the transcriptional function of Tat (Haasnoot et al, 2007) . Here, we used this system to test whether the function of Tat RSS can be complemented by the RHBV NS3 protein, which exclusively binds to short dsRNA molecules (Hemmes et al, 2007) and is therefore not expected to modulate the IFN pathway. An increasing amount of NS3 expression plasmid was co-transfected with a Tat negative HIV-1 variant (HIV-rtTA-Tat fs ) construct in HEK293T cells and the production of HIV-1 was monitored. Markedly, the RHBV NS3 protein was able to rescue virus production in trans to approximately the same extent as HIV-1 Tat (Fig 1B) . The reason that more NS3 than Tat vector is needed could be due to differences in the RSS mechanism-siRNA binding versus Dicer blocking-or the protein's intracellular localization/stability/concentration, but this was not investigated further. Given the established role of NS3 in counteracting antiviral RNAi (Bucher et al, 2003; Hemmes et al, 2007) , this result indicates that the production of HIV-1 is restricted by the RNAi mechanism.
NS3 shows no IFN antagonistic activity
To rule out that the Tat-complementing property of NS3 was based on the modulation of the IFN pathway, this effect was probed in mammalian cells (HEK293T) using a firefly luciferase reporter construct under the control of an IFN-b inducible promoter and Renilla luciferase as an internal control (Fig 2) . As a positive control, firefly luciferase expression-as a measure of IFN production-was induced by poly I:C, and this stimulatory effect was significantly reduced in the presence of the IFN-antagonistic VP35 protein of Ebola virus (Cardenas et al, 2006) . As expected, the RHBV NS3 protein showed no IFN antagonistic activity, HEK293T cells were co-transfected with HIV-rtTA-Tat wt and HIV-rtTA-Tat fs (100 ng) in combination with increasing amounts (10, 100, 600 and 900 ng) of NS3 or Tat expression plasmids. The vector expressing MBP (900 ng) was used as a negative control. The production of HIV-1 was determined 2 days posttransfection by detecting CA-p24 in the supernatant using ELISA. The mean of at least three independent experiments is shown with standard error. ELISA, enzyme-linked immunosorbent assay; GFP, green fluorescence protein; HIV-1, human immunodeficiency virus type 1; MBP, maltose-binding protein; NS3, non-structural protein 3; NS3m, mutant protein; RSS, RNA silencing suppressor; Tat, transactivator of transcription.
Plant viral RNAi suppressor complements HIV-1 Tat E. Schnettler et al yielding the same firefly luciferase expression as the negative control (empty vector). We also tested the Tat wild-type HIV-1 variant (HIV-rtTA-Tat wt ) and the Tat negative HIV-1 variant (HIV-rtTA-Tat fs ) constructs for their ability to induce IFN in this assay; no such activity was measured (data not shown). Next, the possible involvement of the PKR component of the IFN pathway was tested by performing NS3 complementation in the presence of 2-aminopurine, a specific PKR inhibitor (Lu & Cullen, 2004) . NS3 maintained Tat-complementation activity with 2-aminopurine (supplementary Fig S1 online) , confirming that PKR is not involved. Thus, Tat inactivation and NS3 complementation do not have an impact on the IFN pathway.
NS3 RSS activity requires dsRNA-binding
Next, we tested whether NS3 requires its RNA-binding domain for HIV-1 trans-complementation. By substituting a triple lysine motif (positions 173-175) with alanines, an NS3 mutant (NS3m) was obtained that is defective in siRNA binding (Fig 3A) and in suppressing antiviral RNAi in plants (data not shown). As the anti-HIV effect of the RNAi pathway might use miRNAs (Triboulet et al, 2007) , the NS3m was tested for its ability to bind to miRNAs using an electrophoretic mobility shift assay (Fig 3B) . In comparison to wild-type NS3, which is known to bind to miRNA and siRNA duplexes with high affinity (Fig 3C,D ; Hemmes et al, 2007) , this NS3m was unable to interact with miRNA molecules, even at the highest NS3 protein concentration (Fig 3B) . The NS3m was subsequently tested in the HIV-1 trans-complementation assay (Fig 4) , after confirming that the NS3m is expressed at a comparable level to the wild-type NS3, in the transfected cells (Fig 1A) . Unlike wild-type NS3, NS3m was not able to restore the virus production defect of HIV-rtTA-Tat fs at any of the concentrations tested.
Whether NS3 is able to block the miRNA pathway in human cells was determined by using a firefly luciferase reporter containing multiple miR-30 target sites for either the sense (pCMV-luc-miR30-P) or antisense (pCMV-luc-miR30-AP) strand. This reporter is normally tested in co-transfection with an excess of miR-30 expression vector (Zeng et al, 2003) , which might mask a subsequent RNAi suppression effect. HEK293T cells that express endogenous miR-30, where both strands can act as guide strands (Zeng et al, 2003) , were co-transfected with NS3 and either pCMV-luc-miR30-P (Fig 5, left panel) or pCMV-luc-miR30-AP (supplementary Fig S2 online) . Several controls were included: first, we used a control luciferase reporter with randomized miRNA target sites (pCMV-luc-random; Fig 5, right panel) ; second, NS3m and MBP were co-transfected as controls for NS3 RSS activity. Luciferase expression was measured 2 days posttransfection. We observed a modest stimulatory effect of NS3 on pCMV-luc-miR30-P (Fig 5, left panel) and aminopurine (supplementary Fig S2 online) , but not on the pCMV-luc-random control (Fig 5, right panel) , suggesting that NS3 is able to inhibit endogenous miRNA action in mammalian cells.
Here, we have shown that a plant viral RSS protein that lacks IFN antagonistic properties can functionally replace the HIV-1 Tat RSS function and that this complementation is based on the sequestration of small dsRNA. These results corroborate further the RSS function of HIV-1 Tat (Bennasser et al, 2005; Haasnoot et al, 2007) , which has been questioned by others (Lin & Cullen, 2007) . Although cross-kingdom suppression of RNA silencing has been reported for several viral RSS proteins (Dunoyer et al, 2004; Schnettler et al, 2008) , this is the first report, to our knowledge, of cross-kingdom RSS activity in a mammalian viral complementation assay. These results are in line with the observation that knockdown of the RNAi pathway by Drosha or Dicer silencing enhances HIV-1 replication (Triboulet et al, 2007) . The ongoing debate about the physiological relevance of RNAi as an antiviral mechanism is spurred, in part owing to the presence of the antiviral IFN pathway (reviewed by Gantier & Williams, 2007) . The results show that a plant virus-encoded RSS protein with well-defined biochemical activity can be used as a powerful tool to analyse the contribution of the antiviral RNAi pathway in mammalian systems in the presence of the IFN pathway. It is noted that other eukaryotes encode an alternative innate immune response next to the RNAi pathway (Dangl & Jones, 2001; Arbouzova & Zeidler, 2006) . Taken together, we have shown that the production of HIV-1 is limited by endogenous small RNAs and that viral RSS function can counteract this restriction.
METHODS
Plasmid constructs. Expression plasmids for MBP-NS3, MBPNS3m, VP35, Tat, HIV-rtTA-Tat wt and HIV-rtTA-Tat fs were described previously (Haasnoot et al, 2007; Schnettler et al, 2008) . miRNA-based firefly luciferase sensor constructs have also been described previously (Zeng et al, 2003) . Cell culture and transfection. HEK293T cells were grown as a monolayer in DMEM (Gibco BRL, Breda, the Netherlands) supplemented with 10% FCS (Hyclone, Etten-Leur, the Netherlands), streptomycin (100 mg/ml) and penicillin (100 U/ml) at 37 1C and For the IFN assay, cells were co-transfected with 500 ng of a firefly luciferase expression plasmid under the control of an IFN b-inducible promoter, IFNb-luc, 2 ng of a Renilla luciferase expression plasmid, 100 ng of poly I:C and 400 ng of pBluescript (Stratagene, Huissen, the Netherlands) or plasmids encoding MBP-NS3, MBP-NS3 mutant or VP35. Cells were lysed 3 days posttransfection and luciferase expression was determined using the dual luciferase reporter assay (Promega, Leiden, the Netherlands), according to the manufacturer's protocol.
For the miRNA sensor construct assay, cells were cotransfected with 25 ng firefly luciferase expression plasmid containing target sites for sense or antisense of human miRNA-30 (pCMV-luc-miR30-P or pCMV-luc-miR30-AP), or random miRNA target sites (pCMV-luc-random; Zeng et al, 2003) , 0.5 ng of a Renilla luciferase expression plasmid and constructs encoding MBP-NS3, MBP-NS3m or MBP. At 48 h post-transfection, cells were lysed and assayed for luciferase expression by the dual luciferase assay (Promega).
The HIV Tat complementation assay was performed as described previously (Haasnoot et al, 2007) . Recombinant protein expression and electrophoretic mobility shift assay (EMSA). The wild-type and mutant MBP-NS3 proteins were expressed in BL21 DE3 cells and purified as described by Hemmes et al (2007) . EMSA, either with radioactively labelled siRNA or miRNA molecules, was performed in triplicate as described previously , visualized by overnight exposure to a phosphor screen, scanned (Molecular Dynamics Typhoon Phosphor imager; Amersham Biosciences, Den Bosch, the Netherlands) and a representative picture was shown. in combination with Tat, NS3, NS3 mutant (NS3m) or pBluescript (À; 900 ng). CA-p24 in the culture supernatant was measured at 2 days post-transfection. The mean of at least three independent experiments is shown with standard error. dsRNA, double-stranded RNA; HEK, human embryonic kidney; HIV-1, human immunodeficiency virus type 1; NS3, non-structural protein 3; Tat, transactivator of transcription.
Plant viral RNAi suppressor complements HIV-1 Tat E. Schnettler et al Protein expression in transfected HEK293T cells was analysed by Western blot analysis using a rabbit polyclonal antiserum specific for MBP (BioLabs, Leusden, the Netherlands). As a loading control, b-actin was detected with a mouse monoclonal antibody after stripping of the blot. For visualization, goat alkaline phosphataseconjugated secondary antibodies (Dako/Sigma, Heverlee, Belgium) and NBT-BCIP substrate (Roche, Almere, the Netherlands) were used according to the manufacturer's recommendations. Supplementary information is available at EMBO reports online (http://www.emboreports.org) 
